Mathew Sheridan

2024
The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency
Sheridan, M., Maqbool, M. A., Largeot, A., Clayfield, L., Xu, J., Moncaut, N., Sellers, R., Whittle, J., Paggetti, J., Iqbal, M., Aucagne, R., Delva, L., Baker, S. M., Lie-A-Ling, M., Kouskoff, V. & Lacaud, G., 8 Oct 2024, In: Journal of hematology & oncology. 17, 1, p. 91
Research output: Contribution to journal › Article › peer-review

Research output